Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zealand Pharma A/S (ZLDPF)
OTHER OTC:ZLDPF
Zealand Pharma (ZLDPF) Stock Price & Analysis
57 Followers
ZLDPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$31.81 - $111.44
Previous Close$84.77
Volume1.02K
Average Volume (3M)3.18K
Market Cap
$5.30B
Enterprise Value$5.19B
Total Cash (Recent Filing)kr1.18B
Total Debt (Recent Filing)kr443.47M
Price to Earnings (P/E)-46.8
Beta0.43
Next Earnings
May 16, 2024EPS Estimate
-$0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.81
Shares Outstanding51,283,851
10 Day Avg. Volume1,795
30 Day Avg. Volume3,179
Standard Deviation0.16
R-Squared0.05
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)61.09
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$115.46Price Target Upside33.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Zealand Pharma News
Ownership Overview
0.00%
Insiders
8.96% Mutual Funds
4.62% Other Institutional Investors
86.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ZLDPF FAQ
What was Zealand Pharma A/S’s price range in the past 12 months?
Zealand Pharma A/S lowest stock price was $31.81 and its highest was $111.44 in the past 12 months.
What is Zealand Pharma A/S’s market cap?
Currently, no data Available
When is Zealand Pharma A/S’s upcoming earnings report date?
Zealand Pharma A/S’s upcoming earnings report date is May 16, 2024 which is in 6 days.
How were Zealand Pharma A/S’s earnings last quarter?
Zealand Pharma A/S released its earnings results on Feb 27, 2024. The company reported -$0.638 earnings per share for the quarter, missing the consensus estimate of -$0.551 by -$0.088.
Is Zealand Pharma A/S overvalued?
According to Wall Street analysts Zealand Pharma A/S’s price is currently Undervalued.
Does Zealand Pharma A/S pay dividends?
Zealand Pharma A/S does not currently pay dividends.
What is Zealand Pharma A/S’s EPS estimate?
Zealand Pharma A/S’s EPS estimate is -$0.6.
How many shares outstanding does Zealand Pharma A/S have?
Zealand Pharma A/S has 62,648,010 shares outstanding.
What happened to Zealand Pharma A/S’s price movement after its last earnings report?
Zealand Pharma A/S reported an EPS of -$0.638 in its last earnings report, missing expectations of -$0.551. Following the earnings report the stock price went down -12.621%.
Which hedge fund is a major shareholder of Zealand Pharma A/S?
Currently, no hedge funds are holding shares in ZLDPF
---
Zealand Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$115.46 (33.10% Upside)
$115.46 (33.10% Upside)
Blogger Sentiment
Bullish
ZLDPF Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 6.7%
Last 30 Days ▲ 6.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
170.50%
12-Months-Change
Fundamentals
Return on Equity
-57.74%
Trailing 12-Months
Asset Growth
28.82%
Trailing 12-Months
Company Description
Zealand Pharma A/S
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.
---
ZLDPF Company Deck
---
ZLDPF Earnings Call
Q4 2024
0:00 / 0:00
---
ZLDPF Stock 12 Month Forecast
Average Price Target
$115.46
▲(33.10% Upside)
Technical Analysis
Best Analysts Covering ZLDPF
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+42.33%
reiterated a buy rating 2 months ago
Copying Rajan Sharma's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +42.33% per trade.
---